JP2019501910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019501910A5 JP2019501910A5 JP2018533630A JP2018533630A JP2019501910A5 JP 2019501910 A5 JP2019501910 A5 JP 2019501910A5 JP 2018533630 A JP2018533630 A JP 2018533630A JP 2018533630 A JP2018533630 A JP 2018533630A JP 2019501910 A5 JP2019501910 A5 JP 2019501910A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- ceremony
- salt
- during
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15202764.5 | 2015-12-24 | ||
| EP15202764 | 2015-12-24 | ||
| PCT/GB2016/054069 WO2017109513A1 (en) | 2015-12-24 | 2016-12-23 | Indolinones compounds and their use in the treatment of fibrotic diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019501910A JP2019501910A (ja) | 2019-01-24 |
| JP2019501910A5 true JP2019501910A5 (enExample) | 2021-07-29 |
| JP7068172B2 JP7068172B2 (ja) | 2022-05-16 |
Family
ID=55068868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018533630A Active JP7068172B2 (ja) | 2015-12-24 | 2016-12-23 | インドリノン化合物および線維性疾患の処置におけるそれらの使用 |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US11046672B2 (enExample) |
| EP (2) | EP3394048B1 (enExample) |
| JP (1) | JP7068172B2 (enExample) |
| KR (1) | KR20180128390A (enExample) |
| CN (1) | CN109302846B (enExample) |
| AU (1) | AU2016376011B2 (enExample) |
| BR (1) | BR112018013033A2 (enExample) |
| CA (1) | CA3009778A1 (enExample) |
| CL (1) | CL2018001742A1 (enExample) |
| CO (1) | CO2018007663A2 (enExample) |
| DK (1) | DK3722291T3 (enExample) |
| EA (1) | EA038796B1 (enExample) |
| ES (2) | ES2956820T3 (enExample) |
| FI (1) | FI3722291T3 (enExample) |
| HR (1) | HRP20230833T1 (enExample) |
| HU (1) | HUE062784T2 (enExample) |
| IL (1) | IL260221A (enExample) |
| LT (1) | LT3722291T (enExample) |
| MX (1) | MX379859B (enExample) |
| MY (1) | MY195904A (enExample) |
| PH (1) | PH12018501575A1 (enExample) |
| PL (1) | PL3722291T3 (enExample) |
| PT (1) | PT3722291T (enExample) |
| RS (1) | RS64703B1 (enExample) |
| SG (1) | SG11201805423TA (enExample) |
| SI (1) | SI3722291T1 (enExample) |
| SM (1) | SMT202300260T1 (enExample) |
| WO (1) | WO2017109513A1 (enExample) |
| ZA (1) | ZA201804950B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102733897B1 (ko) | 2015-12-24 | 2024-11-22 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | Cftr 조절제 및 이의 사용방법 |
| EP3426649B1 (en) * | 2016-03-08 | 2020-07-22 | Respivert Limited | Indole derivatives and their use as protein kinase inhibitors |
| US11839616B2 (en) | 2017-08-24 | 2023-12-12 | The Regents Of The University Of California | Ocular pharmaceutical compositions |
| CN109678810B (zh) * | 2019-01-23 | 2022-10-28 | 南京工业大学 | 一种1,2-氧氮杂环丁烷类化合物及其制备方法与应用 |
| CA3159601A1 (en) * | 2019-11-20 | 2021-05-27 | Angion Biomedica Corp. | Methods for treating inflammatory bowel disease |
| CN111789842B (zh) * | 2020-08-07 | 2021-09-21 | 南开大学 | 尼达尼布在制备用于治疗炎症性肠病的药物中的应用 |
| KR102739882B1 (ko) * | 2021-04-02 | 2024-12-06 | 연세대학교 원주산학협력단 | 로베글리타존을 유효성분으로 하는 안과질환 치료용 조성물 |
| CN113200936B (zh) * | 2021-05-19 | 2022-10-21 | 南京工业大学 | 10-甲基吩噁嗪衍生物、其锆金属有机框架材料及制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA75054C2 (uk) | 1999-10-13 | 2006-03-15 | Бьорінгер Інгельхайм Фарма Гмбх & Ко. Кг | Заміщені в положенні 6 індолінони, їх одержання та їх застосування як лікарського засобу |
| DE10117204A1 (de) | 2001-04-06 | 2002-10-10 | Boehringer Ingelheim Pharma | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| JP2004182726A (ja) * | 2002-11-22 | 2004-07-02 | Yamanouchi Pharmaceut Co Ltd | ２−オキソインドリン誘導体 |
| US20060154939A1 (en) | 2004-12-24 | 2006-07-13 | Boehringer Ingelheim International Gmbh | Medicaments for the Treatment or Prevention of Fibrotic Diseases |
| PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
| US7692005B2 (en) * | 2005-07-13 | 2010-04-06 | Allergan, Inc. | Kinase inhibitors |
| EP2303841A1 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| EP3426649B1 (en) | 2016-03-08 | 2020-07-22 | Respivert Limited | Indole derivatives and their use as protein kinase inhibitors |
-
2016
- 2016-12-23 HR HRP20230833TT patent/HRP20230833T1/hr unknown
- 2016-12-23 CN CN201680082097.2A patent/CN109302846B/zh not_active Expired - Fee Related
- 2016-12-23 KR KR1020187020374A patent/KR20180128390A/ko not_active Withdrawn
- 2016-12-23 PT PT201620432T patent/PT3722291T/pt unknown
- 2016-12-23 ES ES20162043T patent/ES2956820T3/es active Active
- 2016-12-23 DK DK20162043.2T patent/DK3722291T3/da active
- 2016-12-23 FI FIEP20162043.2T patent/FI3722291T3/fi active
- 2016-12-23 MY MYPI2018001087A patent/MY195904A/en unknown
- 2016-12-23 JP JP2018533630A patent/JP7068172B2/ja active Active
- 2016-12-23 BR BR112018013033A patent/BR112018013033A2/pt not_active Application Discontinuation
- 2016-12-23 HU HUE20162043A patent/HUE062784T2/hu unknown
- 2016-12-23 SI SI201631745T patent/SI3722291T1/sl unknown
- 2016-12-23 EP EP16820318.0A patent/EP3394048B1/en active Active
- 2016-12-23 SM SM20230260T patent/SMT202300260T1/it unknown
- 2016-12-23 US US16/066,043 patent/US11046672B2/en not_active Expired - Fee Related
- 2016-12-23 RS RS20230860A patent/RS64703B1/sr unknown
- 2016-12-23 ES ES16820318T patent/ES2796358T3/es active Active
- 2016-12-23 CA CA3009778A patent/CA3009778A1/en not_active Abandoned
- 2016-12-23 AU AU2016376011A patent/AU2016376011B2/en not_active Ceased
- 2016-12-23 EA EA201891506A patent/EA038796B1/ru unknown
- 2016-12-23 MX MX2018007852A patent/MX379859B/es unknown
- 2016-12-23 EP EP20162043.2A patent/EP3722291B1/en active Active
- 2016-12-23 PL PL20162043.2T patent/PL3722291T3/pl unknown
- 2016-12-23 WO PCT/GB2016/054069 patent/WO2017109513A1/en not_active Ceased
- 2016-12-23 LT LTEP20162043.2T patent/LT3722291T/lt unknown
- 2016-12-23 SG SG11201805423TA patent/SG11201805423TA/en unknown
-
2018
- 2018-06-24 IL IL260221A patent/IL260221A/en unknown
- 2018-06-25 CL CL2018001742A patent/CL2018001742A1/es unknown
- 2018-07-23 ZA ZA201804950A patent/ZA201804950B/en unknown
- 2018-07-24 CO CONC2018/0007663A patent/CO2018007663A2/es unknown
- 2018-07-24 PH PH12018501575A patent/PH12018501575A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019501910A5 (enExample) | ||
| JP2016121196A5 (enExample) | ||
| HRP20230833T1 (hr) | Spojevi indolinona i njihova uporaba u liječenju fibroznih bolesti | |
| JP2018535963A5 (enExample) | ||
| JP2017507160A5 (enExample) | ||
| JP2019524883A5 (enExample) | ||
| JP2009507909A5 (enExample) | ||
| JP2018070614A5 (enExample) | ||
| JP2017523225A5 (enExample) | ||
| JP2016540742A5 (enExample) | ||
| JP2014037426A5 (enExample) | ||
| JP2015521167A5 (enExample) | ||
| JP2015528812A5 (enExample) | ||
| JP2018515495A5 (enExample) | ||
| JP2017510643A5 (enExample) | ||
| JP2012532112A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2012526728A5 (enExample) | ||
| JP2016522254A5 (enExample) | ||
| JP2015500307A5 (enExample) | ||
| JP2016519680A5 (enExample) | ||
| JP2018536648A5 (enExample) | ||
| JP2019517463A5 (enExample) | ||
| JP2018529650A5 (enExample) | ||
| RU2010143857A (ru) | Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибриторов parp и ингибиторов полимеризации тубулина |